BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30333957)

  • 1. An
    van de Merbel AF; van der Horst G; van der Mark MH; van Uhm JIM; van Gennep EJ; Kloen P; Beimers L; Pelger RCM; van der Pluijm G
    Front Oncol; 2018; 8():400. PubMed ID: 30333957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CWR22 xenograft as an ex vivo human tumor model for prostate cancer gene therapy.
    Cheng L; Sun J; Pretlow TG; Culp J; Yang NS
    J Natl Cancer Inst; 1996 May; 88(9):607-11. PubMed ID: 8609662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo tissue slice culture system to measure drug-response rates of hepatic metastatic colorectal cancer.
    Martin SZ; Wagner DC; Hörner N; Horst D; Lang H; Tagscherer KE; Roth W
    BMC Cancer; 2019 Nov; 19(1):1030. PubMed ID: 31675944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response.
    Zhang F; Wang W; Long Y; Liu H; Cheng J; Guo L; Li R; Meng C; Yu S; Zhao Q; Lu S; Wang L; Wang H; Wen D
    Cancer Commun (Lond); 2018 Sep; 38(1):60. PubMed ID: 30257718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors.
    Centenera MM; Gillis JL; Hanson AR; Jindal S; Taylor RA; Risbridger GP; Sutherland PD; Scher HI; Raj GV; Knudsen KE; Yeadon T; ; Tilley WD; Butler LM
    Clin Cancer Res; 2012 Jul; 18(13):3562-70. PubMed ID: 22573351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing the Utility of
    Perez LM; Nonn L
    Front Oncol; 2022; 12():864723. PubMed ID: 35433436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo culture of head and neck cancer explants in cell sheet for testing chemotherapeutic sensitivity.
    Lee J; You JH; Shin D; Roh JL
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2497-2507. PubMed ID: 32620987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in prostate cancer study: 3D cell culture enables the ex vivo reproduction of tumor characteristics].
    Tostivint V; Racaud-Sultan C; Roumiguié M; Soulié M; Gamé X; Beauval JB
    Presse Med; 2017 Oct; 46(10):954-965. PubMed ID: 28967525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-Dimensional
    Chen S; Chen C; Hu Y; Zhu C; Luo X; Wang L; Wang X; Sun X; Chen X; Xie W; Lou H; Huang X; Li C; Xu J; Xue X; Shen X
    Front Oncol; 2020; 10():614096. PubMed ID: 33659211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organotypic slice cultures of pancreatic ductal adenocarcinoma preserve the tumor microenvironment and provide a platform for drug response.
    Lim CY; Chang JH; Lee WS; Lee KM; Yoon YC; Kim J; Park IY
    Pancreatology; 2018 Dec; 18(8):913-927. PubMed ID: 30292644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer.
    Nanni S; Priolo C; Grasselli A; D'Eletto M; Merola R; Moretti F; Gallucci M; De Carli P; Sentinelli S; Cianciulli AM; Mottolese M; Carlini P; Arcelli D; Helmer-Citterich M; Gaetano C; Loda M; Pontecorvi A; Bacchetti S; Sacchi A; Farsetti A
    Mol Cancer Res; 2006 Feb; 4(2):79-92. PubMed ID: 16513839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal Carcinoma.
    Roelants C; Pillet C; Franquet Q; Sarrazin C; Peilleron N; Giacosa S; Guyon L; Fontanell A; Fiard G; Long JA; Descotes JL; Cochet C; Filhol O
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31963500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery.
    Sivakumar R; Chan M; Shin JS; Nishida-Aoki N; Kenerson HL; Elemento O; Beltran H; Yeung R; Gujral TS
    Oncoimmunology; 2019; 8(12):e1670019. PubMed ID: 31741771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histoculture and the immunodeficient mouse come to the cancer clinic - rational approaches to individualizing cancer-therapy and new drug-evaluation (review).
    Hoffman R
    Int J Oncol; 1992 Sep; 1(4):467-74. PubMed ID: 21584568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo culture of tumor cells from N-methyl-N-nitrosourea-induced bladder cancer in rats: Development of organoids and an immortalized cell line.
    Yoshida T; Kates M; Sopko NA; Liu X; Singh AK; Bishai WR; Joice G; McConkey DJ; Bivalacqua TJ
    Urol Oncol; 2018 Apr; 36(4):160.e23-160.e32. PubMed ID: 29288005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual Susceptibility Analysis Using Patient-derived Slice Cultures of Colorectal Carcinoma.
    Sönnichsen R; Hennig L; Blaschke V; Winter K; Körfer J; Hähnel S; Monecke A; Wittekind C; Jansen-Winkeln B; Thieme R; Gockel I; Grosser K; Weimann A; Kubick C; Wiechmann V; Aigner A; Bechmann I; Lordick F; Kallendrusch S
    Clin Colorectal Cancer; 2018 Jun; 17(2):e189-e199. PubMed ID: 29233603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional ex vivo assay to detect PARP1-EJ repair and radiosensitization by PARP-inhibitor in prostate cancer.
    Köcher S; Beyer B; Lange T; Nordquist L; Volquardsen J; Burdak-Rothkamm S; Schlomm T; Petersen C; Rothkamm K; Mansour WY
    Int J Cancer; 2019 Apr; 144(7):1685-1696. PubMed ID: 30478958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trastuzumab and docetaxel in a preclinical organotypic breast cancer model using tissue slices from mammary fat pad: Translational relevance.
    Vesci L; Carollo V; Roscilli G; Aurisicchio L; Ferrara FF; Spagnoli L; De Santis R
    Oncol Rep; 2015 Sep; 34(3):1146-52. PubMed ID: 26133490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combination therapy with a novel bisphosphonate, minodronate (YM529), and docetaxel on a model of bone metastasis by human transitional cell carcinoma.
    Inoue K; Karashima T; Fukata S; Nomura A; Kawada C; Kurabayashi A; Furihata M; Ohtsuki Y; Shuin T
    Clin Cancer Res; 2005 Sep; 11(18):6669-77. PubMed ID: 16166446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.